NCT02001181View on ClinicalTrials.gov

Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema)

PHASE2CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Dermatitis, Atopic
Interventions
DRUG

Tofacitinib ointment 20mg/g

Tofacitinib ointment 20mg/g twice daily (BID) for 4 weeks

DRUG

Placebo ointment (Vehicle)

Placebo ointment (vehicle) twice daily (BID) for 4 weeks

Trial Locations (5)

K9J 1Z2

SKiN Centre for Dermatology, Peterborough

L4B 1A5

The Centre for Dermatology, Richmond Hill

N2J 1C4

K. Papp Clinical Research, Waterloo

H2K 4L5

Innovaderm Research Inc., Montreal

G1V 4X7

Centre de Recherche Dermatologique du Quebec metropolitain, Québec

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02001181 - Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema) | Biotech Hunter | Biotech Hunter